These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34060932)

  • 1. Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation.
    Raccah BH; Erlichman Y; Pollak A; Matok I; Muszkat M
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):601-610. PubMed ID: 34060932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study.
    Rodríguez-Pascual C; Torres-Torres I; Gómez-Quintanilla A; Ferrero-Martínez AI; Sharma J; Guitián A; Basalo MC; Montero-Magan M; Vilches-Moraga A; Olcoz-Chiva MT; Paredes-Galán E; Rodríguez-Artalejo F
    J Am Med Dir Assoc; 2018 Nov; 19(11):936-941. PubMed ID: 29891182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.
    Shurrab M; Jackevicius CA; Austin PC; Tu K; Qiu F; Caswell J; Michael F; Andrade JG; Ko DT
    J Interv Card Electrophysiol; 2023 Apr; 66(3):629-635. PubMed ID: 36149579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants.
    Lee JY; Oh IY; Lee JH; Kim SY; Kwon SS; Yang HJ; Kim YK; Bang SM
    Thromb Res; 2020 Nov; 195():243-249. PubMed ID: 32823239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study.
    Zhang Y; Souverein PC; Gardarsdottir H; van den Ham HA; Maitland-van der Zee AH; de Boer A
    Br J Clin Pharmacol; 2020 Jun; 86(6):1150-1164. PubMed ID: 32022295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Differences in Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis.
    Raccah BH; Perlman A; Zwas DR; Hochberg-Klein S; Masarwa R; Muszkat M; Matok I
    Ann Pharmacother; 2018 Nov; 52(11):1135-1142. PubMed ID: 29681165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.
    Deitelzweig S; Farmer C; Luo X; Li X; Vo L; Mardekian J; Fahrbach K; Ashaye A
    Curr Med Res Opin; 2018 Mar; 34(3):487-498. PubMed ID: 29188721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.
    Pham P; Schmidt S; Lesko L; Lip GYH; Brown JD
    JAMA Netw Open; 2020 Apr; 3(4):e203593. PubMed ID: 32329770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data.
    Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H
    Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.
    Douros A; Renoux C; Yin H; Filion KB; Suissa S; Azoulay L
    Am J Med; 2019 Feb; 132(2):191-199.e12. PubMed ID: 30691551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
    Liu X; Huang M; Ye C; Xiao X; Yan C
    Clin Cardiol; 2021 Apr; 44(4):472-480. PubMed ID: 33682184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Concurrent Use of Amiodarone and DOACs and Risk of Bleeding in Patients With Atrial Fibrillation.
    Shurrab M; Jackevicius CA; Austin PC; Tu K; Qiu F; Singh SM; Crystal E; Caswell J; Michael F; Andrade JG; Ko DT
    Am J Cardiol; 2023 Jan; 186():58-65. PubMed ID: 36343447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.